Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2010; 16(32): 4066-4071
Published online Aug 28, 2010. doi: 10.3748/wjg.v16.i32.4066
Published online Aug 28, 2010. doi: 10.3748/wjg.v16.i32.4066
Table 2 Quality of life, pain scores and analgesic usage in disease duration-matched patients with chronic pancreatitis
| CP patients on Antox (n = 28) | CP patients NOT on Antox (n = 28) | P-value | |
| Median visual analogue pain scores (range 0-10) | 3 (0-8) | 6 (0-8) | < 0.01 (Mann-Whitney U-test) |
| Patients taking analgesics | 16 | 26 | < 0.01 |
| Patients taking opiate analgesics | 11 | 23 | < 0.01 |
| Diabetes | 10 (36%) | 11 (39%) | 0.80 |
| Pancreatic exocrine supplements | 14 (50%) | 16 (57%) | 0.60 |
- Citation: Shah NS, Makin AJ, Sheen AJ, Siriwardena AK. Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol 2010; 16(32): 4066-4071
- URL: https://www.wjgnet.com/1007-9327/full/v16/i32/4066.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i32.4066